# Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors

> **NCT00543101** · PHASE4 · COMPLETED · sponsor: **Community Research Initiative of New England** · enrollment: 24 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Darunavir (DRV/r)
- **DRUG:** continue on current dual boosted PI

## Key facts

- **NCT ID:** NCT00543101
- **Lead sponsor:** Community Research Initiative of New England
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543101, "Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00543101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*